Share: Facebook Twitter LinkedIn
Activity Provided By:

Paradigm Medical Communications, LLC

Operation Diabetes: Optimizing Use of GLP-1 Receptor Agonists

Access Activity

Overview / Abstract:

Target Audience

This activity has been designed to address the educational needs of primary care clinicians. It may also be of benefit to other healthcare professionals who manage patients with diabetes using glucagon-like peptide-1 (GLP-1) receptor agonists.

Program Overview

The incidence of diabetes, particularly type 2 diabetes (T2D), is increasing, and with this increase comes an associated rise in diabetes complications and comorbidities such as obesity, cardiovascular disease (CVD), and renal disease. There are several classes of agents to treat hyperglycemia from which clinicians can choose. In recent years, data on GLP-1 receptor agonists have emerged demonstrating beneficial extraglycemic effects, yet the level of benefit varies among different members of the class. Most recent guideline recommendations include preferences for GLP-1 receptor agonists to individualize therapy for patients with diabetes and CVD. Despite these benefits, the uptake of and adherence to GLP-1 receptor agonist therapy is low. Because the majority of T2D management occurs in the primary care setting, primary care providers play a crucial role in optimizing T2D therapy. However, primary care providers are challenged to remain abreast of the latest data on GLP-1 receptor agonists, the clinical distinctions between class members, managing side effects, and strategies for patient education about GLP-1 receptor agonists and how to increase adherence to therapy.

Learning Objectives

Upon completion of this activity, participants should be better able to:

Select treatment for patients who have diabetes based on the extraglycemic effects of GLP-1 receptor agonists
Formulate management strategies to relieve common adverse events associated with GLP-1 receptor agonist therapy
Outline key elements of GLP-1 receptor agonist therapy to include in patient education

Expiration

May 15, 2021

Discipline(s)

Physician CME

Format

Online

Credits / Hours

0.5 AMA PRA Category 1 Credit(s)™

Accreditation

ACCME

Presenters / Authors / Faculty

Faculty

Vivian Fonseca, MD
Professor of Medicine and Pharmacology
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences Center
New Orleans, LA

Javier Morales, MD, FACP, FACE
Associate Clinical Professor of Medicine
Donald and Barbara Zucker School of Medicine at Hofstra Northwell
Vice President, Advanced Internal Medicine Group, PC
East Hills, NY

Debbie A. Hinnen, APN, BC-ADM, CDE, FAAN, FAADE
Advanced Practice Nurse and Certified Diabetes Educator
University of Colorado Health
Colorado Springs, CO
Adjunct Faculty, Graduate Nursing Department
Wichita State University
Wichita, KS

Sponsors / Supporters / Grant Providers

Novo Nordisk Inc.

Keywords / Search Terms

Relias LLC Relias LLC., FREE CME., Diabetes Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map